222 Chapter 11 Solnavägen 1, 171 77 Solna, Stockholm, Sweden Tampere University, Faculty of Medicine and Health Technology, Kalevantie 4, 33100 Tampere, Finland S. LEPPÄLÄ Tampere University, Faculty of Medicine and Health Technology, Kalevantie 4, 33100 Tampere, Finland K. LOUVANTO Tampere University, Faculty of Medicine and Health Technology, Kalevantie 4, 33100 Tampere, Finland Tampere University, Department of Obstetrics and Gynaecology, Biokatu 6, 33520 Tampere, Finland C.J.L.M. MEIJER Amsterdam UMC location Vrije Universiteit Amsterdam, Department of Pathology, De Boelelaan 1117, 1081 HV Amsterdam, The Netherlands Cancer Center Amsterdam, Imaging and Biomarkers, Amsterdam, The Netherlands W.J.G. MELCHERS Radboud University Medical Center, Department of Medical Microbiology, Heyendaalseweg 135, 6525 AJ Nijmegen, The Netherlands A.C. MOLIJN Eurofins NMDL-LCPL, Visseringlaan 24K, 2280 CA Rijswijk, The Netherlands B. NEDJAI Queen Mary University of London, Centre for Cancer Screening, Prevention and Early Detection (SPED), Mile End Road, London E1 4NS, London, United Kingdom P. NIEMINEN Helsinki University Hospital, Department of Obstetrics and Gynaecology, Haartmaninkatu 2, 00290 Helsinki, Finland V. PIMENOFF Karolinska Institute, Unit of Cervical Cancer Elimination, Department of Clinical Science, Intervention and Technology (CLINTEC), Solnavägen 1, 171 77 Solna, Stockholm, Sweden N. POLMAN Amsterdam UMC location Vrije Universiteit Amsterdam, Department of Pathology, De Boelelaan 1117, 1081 HV Amsterdam, The Netherlands Cancer Center Amsterdam, Imaging and Biomarkers, Amsterdam, The Netherlands W.G.V. QUINT Eurofins NMDL-LCPL, Visseringlaan 24K, 2280 CA Rijswijk, The Netherlands D. SCIBIOR-BENTKOWSKA Queen Mary University of London, Centre for Cancer Screening, Prevention and Early Detection (SPED), Mile End Road, London E1 4NS, London, United Kingdom
RkJQdWJsaXNoZXIy MjY0ODMw